ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,714.52
-0.34%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Vivoryon Therapeutics Nv (0R3M) Share Price

0R3M Vivoryon Therapeutics Nv

4.71
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Vivoryon Therapeutics Nv LSE:0R3M London Stock Exchange Ordinary Share NL00150002Q7 VIVORYON THERAPEUTICS NV ORD SHRS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 4.71 0.00 0.00 0.00 0.00  722 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics -3.62M -28.34M - N/A 
 Type  Size  Price  Time  Units 
  122 0.771 16:33:58 EUR
 
Recent News
DateTimeSource
HeadlineMore 0R3M News
15/05/202406:00GLOBEVivoryon Therapeutics N.V. to Report Q1 2024 Financial Results and Operational Progress on May 23, 2024
08/05/202406:00GLOBEVivoryon Therapeutics N.V. to Hold its 2024 Annual General Meeting on June 21, 2024
24/04/202406:00GLOBEVivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates
16/04/202406:00GLOBEVivoryon Therapeutics N.V. to Report Full Year 2023 Financial Results and Operational Progress on April 24, 2024
15/03/202406:00UKREGVivoryon Therapeutics N.V. Announces Changes to Board Composition
04/03/202406:00UKREGVivoryon Therapeutics N.V. Provides Update on VIVIAD Phase 2b Study of Varoglutamstat in Early Alzheimer’s Disease
08/01/202406:00GLOBEVivoryon Therapeutics N.V. to Host Investor Meetings in January 2024
Period
Draw mode
Data Downloads for 0R3M

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)
Technical Analysis for Vivoryon Therapeutics Nv
Get quick technical analysis for Vivoryon Therapeutics Nv.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.


Loading Follow Feed...

Latest Vivoryon Therapeutics Nv Articles